PolyNovo Limited (CALZF)
OTCMKTS · Delayed Price · Currency is USD
0.8180
0.00 (0.00%)
Sep 3, 2025, 8:00 PM EDT
PolyNovo Market Cap
PolyNovo has a market cap or net worth of $691.34 million as of September 5, 2025. Its market cap has decreased by -43.51% in one year.
Market Cap
691.34M
Enterprise Value
680.55M
Revenue
84.38M
Ranking
n/a
PE Ratio
79.80
Stock Price
$0.82
Market Cap Chart
Since August 23, 1999, PolyNovo's market cap has increased from 21.04M to 691.34M, an increase of 3,185.83%. That is a compound annual growth rate of 14.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 691.34M | -20.73% |
| Dec 31, 2024 | 872.16M | 12.00% |
| Dec 29, 2023 | 778.69M | -17.56% |
| Dec 30, 2022 | 944.58M | 28.80% |
| Dec 31, 2021 | 733.38M | -62.94% |
| Dec 31, 2020 | 1.98B | 116.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 891.61M |
| Elite Pharmaceuticals | 751.15M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 631.79M |
| CytoDyn | 401.20M |
| Northwest Biotherapeutics | 394.86M |
| American Oncology Network | 353.52M |